The British Pharmacological Society (BPS) announces that the British Journal of Pharmacology (BJP) will accept open access articles, subject to payment of a publication fee
The British Journal of Pharmacology is moving to a mixed revenue model of subscription charges and publication fees.
The open access option will be available to all authors submitting on or after 1 April 2006.
For the remainder of 2006, the publication fee will be US$2500, euro1850 or £1250 +VAT (where applicable).
Articles published with a publication fee will be clearly identified in the online and print editions of the journal with a 'BJP Open' logo (BJPOpen).
Editors will be blind to the author's choice, avoiding any possibility of a conflict of interest during through peer review and acceptance.
Authors paying the publication fee will be entitled to self-archive the published version immediately on publication, in the repositories of their choice, and in any format.
Other articles will continue to be published under Nature Publishing Group's (NPG) exclusive License-to-Publish, where NPG's usual self-archiving policy will apply.
Print subscription prices will be unaffected.
This change follows the introduction of 'Online Open' on the British Journal of Clinical Pharmacology, published by BPS and Blackwell Publishing.
BPS is committed to providing authors with all the relevant publishing options in this period of technology change, while protecting the financial foundations of its publications which support its charitable activities for the advancement of pharmacology.
BJP is published by NPG on behalf of BPS.
NPG publishes the open access title Molecular Systems Biology with Embo, and subscription journals such as Nature and Nature Medicine, as well as other society-owned titles such as Modern Pathology and Kidney International.
The BPS is the primary UK learned society concerned with research into drugs and the way they work.
BPS members work in academia, industry and the health services, and many are medically qualified.
The society covers the whole spectrum of pharmacology, including the laboratory, clinical and toxicological aspects.
